Refractoriness and retreatment in the era of lenalidomide and mABs in the frontline myeloma setting
Refractoriness and retreatment in the era of lenalidomide and mABs in the frontline myeloma setting
Cancer Health Disparities Special Issue - Editorial
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers
Pathogenesis of colon adenocarcinoma in Kerala, India
Perceptions regarding tobacco control strategies amongst female youth in Delhi, India – a qualitative study
Healthcare delivery for non-communicable diseases among breast cancer survivors in Sri Lanka: Is there a missed opportunity?
Sexual and gender-based harassment in oncology
ESMO 2021: Latest in EGFR mutated advanced NSCLC
Choosing Wisely in Medical Oncology
Choosing Wisely Avoiding Wisely: Palliative Care/EOLC in Cancer
The National Cancer Grid - Choosing Wisely India
HPV Vaccination in LMIC -barriers to uptake